Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127843) titled 'Nursing Research on CRS Risk Warning for Patients with Hematological Malignancies Receiving CAR-T Therapy' on July 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Hematological malignancies, CAR-T therapy-related cytokine release syndrome (CRS)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-25
Target Sample Size: Observation group:215;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=330521
Published by HT Digital Content Servic...